Report Detail
Global Buprenorphine Hydrochloride Market Insights, Forecast to 2025
- RnM2492287 |
- 02 April, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
USA is the dominate consumer in buprenorphine hydrochloride industry. The sales volume of USA was 5312 kg in 2015, occupied about 48.11% of the total amount. Europe is the second one, with the sales volume of 4222 kg, and the sales market share of 38.24% in 2015.
The global Buprenorphine Hydrochloride market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Buprenorphine Hydrochloride market based on company, product type, end user and key regions.
This report studies the global market size of Buprenorphine Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Buprenorphine Hydrochloride in these regions.
This research report categorizes the global Buprenorphine Hydrochloride market by top players/brands, region, type and end user. This report also studies the global Buprenorphine Hydrochloride market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Market size by Product
Type I
Type II
Market size by End User
Analgesic
Opioid Antagonist
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Buprenorphine Hydrochloride market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Buprenorphine Hydrochloride market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Buprenorphine Hydrochloride companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Buprenorphine Hydrochloride submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Buprenorphine Hydrochloride are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Buprenorphine Hydrochloride market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Buprenorphine Hydrochloride Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Buprenorphine Hydrochloride Market Size Growth Rate by Product
- 1.4.2 Type I
- 1.4.3 Type II
- 1.5 Market by End User
- 1.5.1 Global Buprenorphine Hydrochloride Market Size Growth Rate by End User
- 1.5.2 Analgesic
- 1.5.3 Opioid Antagonist
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Buprenorphine Hydrochloride Market Size
- 2.1.1 Global Buprenorphine Hydrochloride Revenue 2014-2025
- 2.1.2 Global Buprenorphine Hydrochloride Sales 2014-2025
- 2.2 Buprenorphine Hydrochloride Growth Rate by Regions
- 2.2.1 Global Buprenorphine Hydrochloride Sales by Regions
- 2.2.2 Global Buprenorphine Hydrochloride Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Buprenorphine Hydrochloride Sales by Manufacturers
- 3.1.1 Buprenorphine Hydrochloride Sales by Manufacturers
- 3.1.2 Buprenorphine Hydrochloride Sales Market Share by Manufacturers
- 3.1.3 Global Buprenorphine Hydrochloride Market Concentration Ratio (CR5 and HHI)
- 3.2 Buprenorphine Hydrochloride Revenue by Manufacturers
- 3.2.1 Buprenorphine Hydrochloride Revenue by Manufacturers (2014-2019)
- 3.2.2 Buprenorphine Hydrochloride Revenue Share by Manufacturers (2014-2019)
- 3.3 Buprenorphine Hydrochloride Price by Manufacturers
- 3.4 Buprenorphine Hydrochloride Manufacturing Base Distribution, Product Types
- 3.4.1 Buprenorphine Hydrochloride Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Buprenorphine Hydrochloride Product Type
- 3.4.3 Date of International Manufacturers Enter into Buprenorphine Hydrochloride Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Buprenorphine Hydrochloride Sales by Product
- 4.2 Global Buprenorphine Hydrochloride Revenue by Product
- 4.3 Buprenorphine Hydrochloride Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Buprenorphine Hydrochloride Breakdown Data by End User
6 North America
- 6.1 North America Buprenorphine Hydrochloride by Countries
- 6.1.1 North America Buprenorphine Hydrochloride Sales by Countries
- 6.1.2 North America Buprenorphine Hydrochloride Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Buprenorphine Hydrochloride by Product
- 6.3 North America Buprenorphine Hydrochloride by End User
7 Europe
- 7.1 Europe Buprenorphine Hydrochloride by Countries
- 7.1.1 Europe Buprenorphine Hydrochloride Sales by Countries
- 7.1.2 Europe Buprenorphine Hydrochloride Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Buprenorphine Hydrochloride by Product
- 7.3 Europe Buprenorphine Hydrochloride by End User
8 Asia Pacific
- 8.1 Asia Pacific Buprenorphine Hydrochloride by Countries
- 8.1.1 Asia Pacific Buprenorphine Hydrochloride Sales by Countries
- 8.1.2 Asia Pacific Buprenorphine Hydrochloride Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Buprenorphine Hydrochloride by Product
- 8.3 Asia Pacific Buprenorphine Hydrochloride by End User
9 Central & South America
- 9.1 Central & South America Buprenorphine Hydrochloride by Countries
- 9.1.1 Central & South America Buprenorphine Hydrochloride Sales by Countries
- 9.1.2 Central & South America Buprenorphine Hydrochloride Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Buprenorphine Hydrochloride by Product
- 9.3 Central & South America Buprenorphine Hydrochloride by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Buprenorphine Hydrochloride by Countries
- 10.1.1 Middle East and Africa Buprenorphine Hydrochloride Sales by Countries
- 10.1.2 Middle East and Africa Buprenorphine Hydrochloride Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Buprenorphine Hydrochloride by Product
- 10.3 Middle East and Africa Buprenorphine Hydrochloride by End User
11 Company Profiles
- 11.1 Siegfried
- 11.1.1 Siegfried Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Siegfried Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Siegfried Buprenorphine Hydrochloride Products Offered
- 11.1.5 Siegfried Recent Development
- 11.2 Sanofi
- 11.2.1 Sanofi Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sanofi Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sanofi Buprenorphine Hydrochloride Products Offered
- 11.2.5 Sanofi Recent Development
- 11.3 Johnson Matthey
- 11.3.1 Johnson Matthey Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Johnson Matthey Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Johnson Matthey Buprenorphine Hydrochloride Products Offered
- 11.3.5 Johnson Matthey Recent Development
- 11.4 Mallinckrodt
- 11.4.1 Mallinckrodt Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Mallinckrodt Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Mallinckrodt Buprenorphine Hydrochloride Products Offered
- 11.4.5 Mallinckrodt Recent Development
- 11.5 Noramco
- 11.5.1 Noramco Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Noramco Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Noramco Buprenorphine Hydrochloride Products Offered
- 11.5.5 Noramco Recent Development
- 11.6 Unichemlabs
- 11.6.1 Unichemlabs Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Unichemlabs Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Unichemlabs Buprenorphine Hydrochloride Products Offered
- 11.6.5 Unichemlabs Recent Development
- 11.7 Arevipharma
- 11.7.1 Arevipharma Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Arevipharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Arevipharma Buprenorphine Hydrochloride Products Offered
- 11.7.5 Arevipharma Recent Development
- 11.8 Resonance-labs
- 11.8.1 Resonance-labs Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Resonance-labs Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Resonance-labs Buprenorphine Hydrochloride Products Offered
- 11.8.5 Resonance-labs Recent Development
- 11.9 Sun Pharma
- 11.9.1 Sun Pharma Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Sun Pharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Sun Pharma Buprenorphine Hydrochloride Products Offered
- 11.9.5 Sun Pharma Recent Development
- 11.10 Rusan Pharma
- 11.10.1 Rusan Pharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Rusan Pharma Buprenorphine Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Rusan Pharma Buprenorphine Hydrochloride Products Offered
- 11.10.5 Rusan Pharma Recent Development
- 11.11 Micro Orgo Chem
- 11.12 Faranshimi
12 Future Forecast
- 12.1 Buprenorphine Hydrochloride Market Forecast by Regions
- 12.1.1 Global Buprenorphine Hydrochloride Sales Forecast by Regions 2019-2025
- 12.1.2 Global Buprenorphine Hydrochloride Revenue Forecast by Regions 2019-2025
- 12.2 Buprenorphine Hydrochloride Market Forecast by Product
- 12.2.1 Global Buprenorphine Hydrochloride Sales Forecast by Product 2019-2025
- 12.2.2 Global Buprenorphine Hydrochloride Revenue Forecast by Product 2019-2025
- 12.3 Buprenorphine Hydrochloride Market Forecast by End User
- 12.4 North America Buprenorphine Hydrochloride Forecast
- 12.5 Europe Buprenorphine Hydrochloride Forecast
- 12.6 Asia Pacific Buprenorphine Hydrochloride Forecast
- 12.7 Central & South America Buprenorphine Hydrochloride Forecast
- 12.8 Middle East and Africa Buprenorphine Hydrochloride Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Buprenorphine Hydrochloride Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Buprenorphine Hydrochloride . Industry analysis & Market Report on Buprenorphine Hydrochloride is a syndicated market report, published as Global Buprenorphine Hydrochloride Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Buprenorphine Hydrochloride market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
